Organ transplantation has become increasingly common as a therapy for end-stage renal,
liver, cardiac and pulmonary disease. The population of patients who have survived organ …

In light of greatly improved long-term patient and graft survival after renal transplantation,
improving other clinical outcomes such as risk of fracture and cardiovascular disease is of …

MBD following kidney transplantation is common and characterized by loss of bone volume
and mineralization abnormalities, often leading to low turnover bone disease. Although …

Background. New and potent immunosuppressive regimens allow for reduced doses of
corticosteroids after renal transplantation. The aims of our study were to investigate whether …

Bone disease is common after renal transplantation. The main syndromes are bone loss
with a consequent fracture rate of 3% per year, osteonecrosis of the hip, and bone pain. The …

Background/Aims: Abnormal bone and mineral metabolism is common in patients with
kidney failure and often persists after successful kidney transplant. Methods: To better …

A prospective randomized study for prevention of postrenal transplantation bone loss.
Background We aimed to investigate different treatment drugs for the prevention of post …

Cardiovascular disease and mineral bone disorders are major contributors to morbidity and
mortality among patients with chronic kidney disease and often persist after renal …

Very rapid bone loss, osteopenia, and osteoporosis have been documented in the first 6 to
12 mo after renal transplantation. Investigated was the effect of treatment with active vitamin …

Kidney transplantation is the optimal form of renal replacement therapy for many with end-
stage kidney disease. However, kidney transplantation comes with a unique set of medical …